Zymeworks ZYME Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's stock issued during period, value, stock options exercised?
- Zymeworks (ZYME) reported stock issued during period, value, stock options exercised of $8.72M in Q1 2026.
- How has Zymeworks's stock issued during period, value, stock options exercised changed year-over-year?
- Zymeworks's stock issued during period, value, stock options exercised increased by 1030.6% year-over-year, from $771K to $8.72M.
- What is the long-term trend for Zymeworks's stock issued during period, value, stock options exercised?
- Over 2 years (2023 to 2025), Zymeworks's stock issued during period, value, stock options exercised has grown at a 84.4% compound annual growth rate (CAGR), from $5.22M to $17.75M.
- What does stock issued during period, value, stock options exercised mean?
- The total cash proceeds received by the company from the exercise of employee or director stock options. This metric highlights the liquidity generated through equity-based compensation programs and the dilution impact on existing shareholders.